1) Lewis P. Rowland (2001). Epilepsy. In: Merritt, Text book of Neurology, edited by Williams & Wlikins Philadelphia, P:8 13-832. 2) Tatum. WO, Liporace. J, Selim. R, Benbadis. SR, Kaplan PW (2004). Updates on the treatment of epilepsy in women. Archives of Internal med. 164(26):137- 45. 3) Backstrom. T, Andersson. A, Andree. L, Pathogenesis in menstrual cycle-linked CNS isorders. Ann N Y Acad Scl. 2003 Dec; 1007:42-53. 4) Herzog AG. (2000), Hormones and epliepsy, Acta neural Scand spuul, 102(175)29-31. 5) Herzog AG. (1999), Psychondoceine asectes of temporolimibie epilepsy: Part II: epilepsy and reproductive steroids, Psychosomatics, 40(2)102-8 6) Herzog. Ag, Kelein. P, Ransil. J (1997), Three Patterns of catmenial epilepsy, Epilepsia, 38(10): 1082-88. 7) Herzog Ag.(1999), Progesterone therapy in women with epilepsy: a Three-years follow up. Neurlogy. 52(9): 1917-19. 8) Weatherford KJ. (1999), Catamenial epilepsy: in search of a clinical ontity and prevalence, J Neurosci Nurs. 31(6):328-31. 9) Herzog AG.( 1 999), Psychoneurondocrine aspects of temporolimbic epilepsy: Part 1: Brainreproductive steroids and emotions, Psychosomatics, 40:95-101. 10) Michael J Amino. (2001), Neuroendocrinology, In: Neurology in general Medicine edited by Williams & Wilkins, Philadephia, p:365-80. 11) Herzog AG.(1995), Progesterone therapy in women with complex partial and secondary generalzed seizures, Meurology, 45(9): 1 669-62. 12) Batesburg. S, Stoffel. B, Bauer J. (2001), Neuroactive steroids and seizuresusceptibility, epilepsy res, 44 : 1 4 1 - 1 5 3 . 13) Mtchedlishvili. Z, Bertram. EH, Kapur J. (2001), Insight in to molecular mechanisms of cat menial epilepsy, J physiology, 537-435-67. 14) springer, ea, morrel. mj, giudice Ic. (1997), seizures distribution in women with localization-related epilepsy, epilepsi,38:233-35. 15) Foldvary-Schaefer. N, Falcone. (2003), Catamenial epilepsy: pathophysiohogy, diagnosis ,and management. Neurology. 1;61(6 supp!2):S2-15. 16) Zahn C. (1999), Catamenial epilepsy, clinical aspects, Neurology, 53(4)s34-s37. 17) Lim. L, Foldvary. N, Mascha. E, lee J. (1999), Acetazikanude in women with epilepsy, epilepsia, 42(6):764-49. 18) Towanabut. S, Chulavatatol. S, Suthisisang. C, Wanakamanee U. (1998), The period prevalence of catamenial epilepsy at Prasat Neurological Institue, Bangkok. J Med Assoc Thai. 81(12);970-7.